These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1973105)
1. Effects of chronic SCH 23390 treatment on dopamine autoreceptor function in rat brain. Lappalainen J; Hietala J; Sjöholm B; Syvälahti E Eur J Pharmacol; 1990 Apr; 179(3):315-21. PubMed ID: 1973105 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. Imperato A; Tanda G; Frau R; Di Chiara G J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912 [TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus. Koulu M; Lappalainen J; Pesonen U; Hietala J; Syvälahti E Eur J Pharmacol; 1988 Oct; 155(3):313-6. PubMed ID: 3069483 [TBL] [Abstract][Full Text] [Related]
4. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors. Jeziorski M; White FJ Synapse; 1989; 4(4):267-80. PubMed ID: 2603146 [TBL] [Abstract][Full Text] [Related]
5. Supersensitivity to a D-1 dopamine receptor agonist and subsensitivity to a D-2 receptor agonist following chronic D-1 receptor blockade. Barone P; Tucci I; Parashos SA; Chase TN Eur J Pharmacol; 1988 May; 149(3):225-32. PubMed ID: 3261693 [TBL] [Abstract][Full Text] [Related]
6. Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin. Lappalainen J; Hietala J; Koulu M; Sjöholm B; Syvälahti E Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):861-72. PubMed ID: 1722342 [TBL] [Abstract][Full Text] [Related]
7. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Wachtel SR; Hu XT; Galloway MP; White FJ Synapse; 1989; 4(4):327-46. PubMed ID: 2532422 [TBL] [Abstract][Full Text] [Related]
8. Acute changes in dopamine levels in rat adrenal glands after administration of dopamine receptor agonists and antagonists. Kujacic M; Svensson K; Löfberg L; Carlsson A Eur J Pharmacol; 1990 Feb; 177(3):163-70. PubMed ID: 1968848 [TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain. Lappalainen J; Hietala J; Koulu M; Seppälä T; Sjöholm B; Syvälahti E J Pharmacol Exp Ther; 1990 Feb; 252(2):845-52. PubMed ID: 2179533 [TBL] [Abstract][Full Text] [Related]
10. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons. Breese GR; Mueller RA Eur J Pharmacol; 1985 Jul; 113(1):109-14. PubMed ID: 2864260 [TBL] [Abstract][Full Text] [Related]
11. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Arnt J; Hyttel J; Perregaard J Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991 [TBL] [Abstract][Full Text] [Related]
12. Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function. A behavioural and biochemical study. Jackson DM; Ross SB; Larsson LG Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):355-65. PubMed ID: 2573842 [TBL] [Abstract][Full Text] [Related]
13. Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats. Longoni R; Spina L; Di Chiara G Eur J Pharmacol; 1987 Feb; 134(2):163-73. PubMed ID: 2883010 [TBL] [Abstract][Full Text] [Related]
14. Opposing effects of D-1 and D-2 receptor antagonists on acetylcholine levels in the rat striatum. Fage D; Scatton B Eur J Pharmacol; 1986 Oct; 129(3):359-62. PubMed ID: 2877889 [TBL] [Abstract][Full Text] [Related]
15. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors. Santiago M; Westerink BH Eur J Pharmacol; 1991 Oct; 204(1):79-85. PubMed ID: 1687125 [TBL] [Abstract][Full Text] [Related]
16. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions. Ajima A; Yamaguchi T; Kato T Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213 [TBL] [Abstract][Full Text] [Related]
17. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists. Carlson JH; Bergstrom DA; Walters JR Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101 [TBL] [Abstract][Full Text] [Related]
18. The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats. Imperato A; Mulas A; Di Chiara G Eur J Pharmacol; 1987 Oct; 142(1):177-81. PubMed ID: 2891544 [TBL] [Abstract][Full Text] [Related]
19. Dissociation of autoreceptor activation and behavioral consequences of low-dose apomorphine treatment. Lynch MR Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(5):689-98. PubMed ID: 1956995 [TBL] [Abstract][Full Text] [Related]
20. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Weick BG; Walters JR Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]